Transcription of Prolotherapy Platelet Rich Plasma Therapies
{{id}} {{{paragraph}}}
Prolotherapy and Platelet Rich Plasma Therapies Page 1 of 24 UnitedHealthcare Commercial Medical Policy Effective 01/01/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare Commercial Medica l Policy Prolotherapy and Platelet Rich Plasma Therapies Policy Number: 2022T0498V Effective Date: January 1, 2022 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Applicable Codes .. 1 Description of Services .. 2 clinical Evidence.
Clinical Evidence . Prolotherapy ... In the fifth trial, effects of prolotherapy could not be determined because the prolotherapy group received strong manipulation and the control injection group only light manipulation. The authors concluded that prolotherapy has not been found to be effective for the treatment of low back and
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}